Industry & Mining · Pharmaceutical active pharmaceutical ingredients (APIs) production

Pharmaceutical active pharmaceutical ingredients (APIs) production in USA in 2026

In 2026, the USA did not produce pharmaceutical active pharmaceutical ingredients — the figure was 0 tonnes. This is paradoxical for a country with the world's largest pharmaceutical industry, but it is explained by the global division of labor: American companies prefer to locate the production of active pharmaceutical ingredients in Poland, Romania, and Portugal, where costs are lower and environmental regulations are stricter. Only the final stages — mixing, dosing, and packaging — remain in the USA. In the global ranking, the country holds 33-th place out of 197.

Data for 2026 · unit: tonnes
Position

USA world ranking

#33 / 197

Country position on the scale from last to first place for this indicator.

US
#33
#197#1
Trend

Change over time

Change in indicator over the available period.

50
1950
400
1990
500
2000
900
2010
1 K
2020
0
2025
0
2026

Values — tonnes

Comparison

Top countries by Pharmaceutical active pharmaceutical ingredients (APIs) production

Where USA stands in the world ranking.

Full world rankingarrow_forward
Related questions

People also search for

Other pages of the reference by this indicator.

Summary

Frequently asked questions

Pharmaceutical active pharmaceutical ingredients (APIs) production in USA — how much?
Based on 2026 data — 0 tonnes. This is rank #33 out of 197 countries.
What is USA's rank by Pharmaceutical active pharmaceutical ingredients (APIs) production?
USA ranks #33 out of 197 countries in the world ranking by «Pharmaceutical active pharmaceutical ingredients (APIs) production».
How has Pharmaceutical active pharmaceutical ingredients (APIs) production changed in USA?
Over the available period the indicator changed from 50 to 0 tonnes.